Systolic heart failure in the elderly: optimizing medical management
Related Experiment Videos
Jonathan P Man1, Bodh I Jugdutt
1Hospital of the University of Pennsylvania-Cardiology, 3400 Spruce Street, Philadelphia, PA 19104, USA. jonathan.man@uphs.upenn.edu
Insights
Elderly patients with heart failure (HF) require tailored pharmacotherapy due to age-related changes affecting drug responses. Current guidelines, often based on younger populations, necessitate updated approaches for optimal HF management in older adults.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Global increase in aging population with hypertension and coronary artery disease.
- High prevalence of heart failure (HF) in the elderly.
- Current HF management guidelines are primarily based on studies in younger populations.
Purpose of the Study:
- To highlight the impact of aging on pharmacotherapeutic responses in HF patients.
- To emphasize the need for optimizing HF management in the elderly.
- To address the gap in evidence for drug efficacy and safety in older adults.
Main Methods:
- Review of existing literature on HF pharmacotherapy in the elderly.
- Analysis of age-related physiological changes affecting drug metabolism and response.
- Evaluation of current HF management guidelines for applicability to older patients.
Main Results:
- Aging alters physiological responses, impacting efficacy and safety of HF drugs.
- Many drugs recommended for HF have not been adequately tested in elderly populations.
- Existing treatment protocols may not be optimal for the unique needs of older HF patients.
Conclusions:
- Physicians must recognize age-specific factors in HF pharmacotherapy.
- Current pharmacotherapeutic agents require careful consideration in elderly patients.
- There is a growing need for novel therapeutic agents specifically developed and tested for the aging HF population.
Abstract:
The aging population with hypertension and coronary artery disease is rapidly increasing worldwide and develops heart failure (HF). A wide range of pharmacotherapeutic drugs are recommended in the HF management guidelines. For the most part, these recommendations are based on the results of studies in the younger population, and most drugs were not adequately tested in the elderly. However, many changes that occur during the aging process affect the response to several of the recommended therapeutic drugs. Physicians will be increasingly involved in managing the expanding elderly population with HF. It is therefore imperative that they recognize ways to use current pharmacotherapeutic agents and the increasing need for novel agents for optimizing the management of the elderly patient with HF.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation IV: Nursing Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System